Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, Nurko S. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999 Nov;29(5):612-26.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Note from the National Guideline Clearinghouse (NGC): The following key points summarize the content of the guideline recommendations. Refer to the full text for additional information, including detailed information on dosing, possible side effects, and other interventions.

Each recommendation is identified as falling into one of five categories of evidence, indicated by a bracketed Roman numeral. The five categories represent varying levels of clinical confidence regarding the recommendation.

Definitions for the categories of evidence (I, II-1, II-2, II-3, III) are provided at the end of the "Major Recommendations" field.

General Recommendations

A thorough history and physical examination are an important part of the complete evaluation of the infant or child with constipation [III].

Performing a thorough history and physical examination is sufficient to diagnose functional constipation in most cases [III].

A stool test for occult blood is recommended in all constipated infants and in those children who also have abdominal pain, failure to thrive, diarrhea or a family history of colonic cancer or polyps [III].

In selected patients, an abdominal radiograph, when interpreted correctly, can be useful to diagnose fecal impaction [II-2].

Rectal biopsy with histopathologic examination and rectal manometry are the only tests that can reliably exclude Hirschsprung disease [II-1].

In selected patients, measurement of transit time using radiopaque markers can determine whether constipation is present [II-2].

Recommendations for Infants

In infants, rectal disimpaction can be carried out with glycerin suppositories. Enemas are to be avoided [II-3].

In infants, juices that contain sorbitol, such as prune, pear, and apple juice, can decrease constipation [II-3].

Barley malt extract, corn syrup, lactulose, or sorbitol (osmotic laxatives) can be used as stool softeners [III].

Mineral oil and stimulant laxatives are not recommended for infants [III].

Recommendations for Children

In children, disimpaction can be achieved with either oral or rectal medication, including enemas [II-3].

In children, a balanced diet, containing whole grains, fruits, and vegetables, is recommended as part of the treatment for constipation [III].

The use of medications in combination with behavioral management can decrease the time to remission in children with functional constipation [I].

Mineral oil (a lubricant) and magnesium hydroxide, lactulose, and sorbitol (osmotic laxatives) are safe and effective medications [I].

Rescue therapy with short-term administration of stimulant laxatives can be useful in selected patients [II-3].

Senna and bisacodyl (stimulant laxatives) can be useful in selected patients who are more difficult to treat [II-1].

Polyethylene glycol electrolyte solution, given in low dosage, may be an effective long-term treatment for constipation that is difficult to manage [III].

Biofeedback therapy can be effective short-term treatment of intractable constipation [II-2].

Definitions:

Categories of the Quality of Evidence

I Evidence obtained from at least one properly designed randomized controlled study.

II-1 Evidence obtained from well-designed cohort or case-controlled trials without randomization.

II-2 Evidence obtained from well-designed cohort or case-controlled analytic studies, preferably from more than one center or research group.

II-3 Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence.

III Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.

CLINICAL ALGORITHM(S)

The original guideline document contains algorithms for:

  • The management of constipation in children one year of age and older
  • The management of constipation in infants less than one year of age

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations" field).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1999 Nov (revised 2006 Sep)

GUIDELINE DEVELOPER(S)

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition - Professional Association

SOURCE(S) OF FUNDING

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

GUIDELINE COMMITTEE

NASPGHAN Constipation Guideline Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee Members: Susan S. Baker, MD (Chair) Buffalo, NY; Gregory S. Liptak, MD, Syracuse, NY; Richard B. Colletti, MD, Burlington, VT; Joseph M. Croffie, MD, Indianapolis, IN; Carlo DiLorenzo, MD, Columbus, OH; Walton Ector, MD, Charleston, SC; Samuel Nurko, MD, Boston, MA

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, Nurko S. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999 Nov;29(5):612-26.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on June 9, 2003. The information was verified by the guideline developer on June 16, 2003. This NGC summary was updated by ECRI on November 14, 2006.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) at (215) 233-0808.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo